In last trading session, Kura Oncology Inc (NASDAQ:KURA) saw 1.21 million shares changing hands with its beta currently measuring 0.40. Company’s recent per share price level of $5.95 trading at $0.22 or 3.84% at ring of the bell on the day assigns it a market valuation of $515.12M. That closing price of KURA’s stock is at a discount of -294.62% from its 52-week high price of $23.48 and is indicating a premium of 9.08% from its 52-week low price of $5.41.
For Kura Oncology Inc (KURA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Kura Oncology Inc (NASDAQ:KURA) trade information
Upright in the green during last session for gaining 3.84%, in the last five days KURA remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $5.95 price level, adding 5.85% to its value on the day. Kura Oncology Inc’s shares saw a change of -31.69% in year-to-date performance and have moved -0.83% in past 5-day. Kura Oncology Inc (NASDAQ:KURA) showed a performance of -1.33% in past 30-days.
Wall Street analysts have assigned a consensus price target of 12.5 to the stock, which implies a rise of 52.4% to its current value. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -84.87% in reaching the projected high whereas dropping to the targeted low would mean a loss of -84.87% for stock’s current value.
Kura Oncology Inc (KURA) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -6.05% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 9.65% while estimates for its earnings growth in next 5 years are of 7.05%.
Kura Oncology Inc (NASDAQ:KURA)’s Major holders
SUVRETTA CAPITAL MANAGEMENT, LLC is the top institutional holder at KURA for having 7.07 million shares of worth $145.56 million. And as of 2024-06-30, it was holding 8.1602 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 6.97 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.0404 of outstanding shares, having a total worth of $143.43 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 2.75 shares of worth $16.38 million or 3.18% of the total outstanding shares. The later fund manager was in possession of 1.95 shares on Mar 31, 2025, making its stake of worth around $11.59 million in the company or a holder of 2.25% of company’s stock.
